Search results

Found 5,185 pages
AUTHOR: Kevin Grogan

Results per page

10 20 50 100

Sort by

Relevance Date

26 Feb 2015:

Pharmacyclics up for sale: Bloomberg

It has been reported by Bloomberg that Pharmacyclics, which discovered the cancer drug Imbruvica, is looking for buyers and partner Johnson & Johnson and Novartis are cited as possible acquirers. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/pharmacyclics_up_for_sale_bloomberg_971114

3 Sep 2013:

Acacia raises £15 million

The UK's Acacia Pharma has raised £15 million to finance late-stage development of its treatments designed to prevent nausea and vomiting in cancer patients. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/acacia_raises_15_million_1005626

9 Jul 2012:

AZ divests Atrium Oncology unit

AstraZeneca has completed the sale of the assets of its subsidiary, Aptium Oncology. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/az_divests_atrium_oncology_unit_977000

15 Jan 2015:

AZ gets boost from Brilinta data

AstraZeneca is celebrating after top-line results from a closely-watched trial of its potential blockbuster Brilinta demonstrated that the bloodthinner demonstrated statistically significant reductions in major cardiovascular thrombotic events in

by Kevin Grogan

https://www.pharmatimes.com/news/az_gets_boost_from_brilinta_data_970868

20 Feb 2015:

Celgene gets Revlimid boost in Europe

Regulators in Europe have followed the example of their counterparts across the Atlantic and expanded approval on Celgene’s big-selling multiple myeloma drug Revlimid to include newly-diagnosed patients. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/celgene_gets_revlimid_boost_in_europe_971074

26 Feb 2015:

Newron Parkinson's drug Xadago gets Europe okay

The European Commission has given the green light to Newron Pharmaceuticals of Italy’s Parkinson’s disease drug Xadago. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/newron_parkinsons_drug_xadago_gets_europe_okay_971112

20 Dec 2013:

Lilly links up with Japan's PeptiDream

Eli Lilly has entered into a collaboration with Japan's PeptiDream to discover and develop novel therapeutic peptides. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/lilly_links_up_with_japans_peptidream_1006215

4 Feb 2015:

Roche leukaemia drug Gazyva succeeds in lymphoma

Roche’s leukaemia drug Gazyva has shown significant benefit in a late-stage trial for refractory indolent non-Hodgkin’s lymphoma, meeting its primary endpoint early. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/roche_leukaemia_drug_gazyva_succeeds_in_lymphoma_970994

7 Sep 2010:

Shire launches bid to buy Movetis

Shire has launched its 19 euros per share offer for Belgium's Movetis. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/shire_launches_bid_to_buy_movetis_982484

1 Feb 2011:

Bayer streamlines healthcare ops

Bayer is putting in place measures which it claims will cut down on administration and promote innovation. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/bayer_streamlines_healthcare_ops_979675